Back to Agenda
Session 10: DIAmond Session: The Safety Pulse: Executive Insights from Global Chief Safety Officers on Maintaining Best-in-Class PV Organizations
Session Chair(s)
Jamie Wilkins, PHARMD
Head, Risk Management Center of Excellence, Pfizer Inc, United States
This fireside chat brings Chief Safety Officers/Heads of Safety from companies of varying sizes to explore the most pressing issues facing pharmacovigilance today. Topics include the future of PV, workforce development and organizational structure, empathetic leadership, the role of AI, and the impact of evolving global regulatory requirements. Attendees will gain firsthand insights into how top safety leaders are navigating change and shaping the future of drug safety.
Learning Objective : At the conclusion of this session, participants should be able to:- Identify current key challenges and opportunities facing global PV organizations
- Contrast approaches for pharmacovigilance leadership best-practices in companies of various sizes
- Describe advice for developing and maintaining best-in-class pharmacovigilance organizations
Speaker(s)
Speaker
Global Head Safety Risk Management, F Hoffmann-La Roche, Switzerland
Speaker
Senior Vice President, Patient Safety Officer , Bristol Myers Squibb, United States
Speaker
Vice President and Head of Patient Safety, Gilead Sciences, United States
Speaker
Vice President Global Patient Safety, Argenx, United States
Have an account?